NZ Breast Cancer Research Review Issue 49
In this issue:
– Neoadjuvant chemotherapy for early breast cancer
– Extended duration of endocrine treatment for early breast cancer
– Adjuvant capecitabine for TNBC after neoadjuvant chemotherapy
– Trastuzumab deruxtecan + pertuzumab for HER2-positive metastatic breast cancer
– 600 vs 400 mg first-line ribociclib in advanced breast cancer
– Second cancers after early invasive breast cancer
– Elinzanetant for vasomotor symptoms after endocrine therapy
– Outcomes of population-based breast cancer screening
– Comparative accuracy of digital breast tomosynthesis and digital mammography
– Breastfeeding during and after breast cancer diagnosis
Expert contributor
Dr David Okonji
MB BCh (UK) FRCP(Lon) MRCPS(Glas) FRACP David Okonji specialises in treating breast and urogenital cancers, as well as melanoma. He has a particular focus on cancer care in the elderly. David currently practises at Wellington Regional Hospital and also undertakes private practice at Bowen Hospital, Wellington. _ David is a Clinical Senior Lecturer at the […]
Expert contributor
Dr Aleksandra Popadich
Dr Popadich is a Breast, Endocrine and General Surgeon based in Wellington, working from Wakefield and Boulcott hospitals. Her main focus is surgical treatment of breast cancers and management of thyroid and parathyroid conditions. She is a member of the American Society of Breast Surgeons, the International Association of Endocrine Surgeons, the Australian and New […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.
